The global vaccine delivery devices market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028. More info:- https://www.imarcgroup.com/vaccine-delivery-devices-market

1. Global Vaccine Delivery
Devices Market
Research and Forecast
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled " Vaccine Delivery
Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2023-2028," the global vaccine delivery devices market size
reached US$ 7.0 Billion in 2022.
Vaccine delivery devices refer to several engineered instruments that carry the
vaccine into or throughout the body. Some of the commonly used products
include syringes and jet injectors, and in terms of components, they can be
categorized into nanoparticles, liposomes, microspheres, micellar, plant-
derived viruses, etc.
These vaccine delivery devices allow targeted delivery or control release of the
biological substances that are developed to protect individuals from bacterial
and virus illnesses by boosting the immune response of the body against the
disease. Consequently, they are extensively utilized in hospitals, clinics, and
other healthcare establishments across the globe.
Request for a PDF sample of this report:
https://www.imarcgroup.com/vaccine -delivery-devices-
market/requestsample

4. Report Description
Global Vaccine Delivery Devices Market Trends:
The increasing technological advancements and the development of electroporation and micro-needles are among
the key factors driving the vaccine delivery devices market. In addition to this, the growing consumer inclination
towards using needle-free delivery systems, owing to the reduced risk of needle stick injuries and enhanced
vaccine immunogenicity, is further stimulating the market growth. Moreover, the launch of various immunization
programs by government bodies across countries aimed at preventing death and disabilities from vaccine-
preventable diseases is acting as another significant growth-inducing factor.
Apart from this, extensive investments by non-governmental organizations (NGOs) in numerous vaccination
programs and campaigns are also positively influencing the global market. Furthermore, the rising focus of key
market players on introducing novel techniques that enhance the therapeutic value of vaccines by lowering
toxicity, the expanding healthcare industry, and the ease of access to medical products and services are expected
to bolster the vaccine delivery devices market over the forecasted period.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/vaccine-delivery-devices-market

5. Report
Segmentation
Breakup by Device:
• Syringes
• Jet Injectors
• Others
Breakup by Route of Administration:
• Intramuscular Vaccination
• Intradermal Vaccination
• Subcutaneous Vaccination
• Others

6. Report
Segmentation
Breakup by End User:
• Hospitals
• Clinics
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• 3M Company
• Becton Dickinson and Company
• Enesi Pharma Limited
• Gerresheimer AG
• INOVIO Pharmaceuticals
• NanoPass
• Panacea Biotec Pharma Limited (Panacea
Biotec)
• Pharmajet Inc.
• Schott AG (Carl-Zeiss-Stiftung)
• Terumo Corporation
• Vaxxas.

8. Key Questions
Answered in
the Report
What was the size of the global vaccine delivery
devices market in 2022?
What is the expected growth rate of the global
vaccine delivery devices market during 2023-2028?
What are the key factors driving the global vaccine
delivery devices market?
What has been the impact of COVID-19 on the global
vaccine delivery devices market?
What is the breakup of the global vaccine delivery
devices market based on the device?
What is the breakup of the global vaccine delivery
devices market based on the route of administration?
What is the breakup of the global vaccine delivery
devices market based on end user?
What are the key regions in the global vaccine
delivery devices market?
Who are the key players/companies in the global
vaccine delivery devices market?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vaccine Delivery Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Device
6.1 Syringes
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Jet Injectors
6.2.1 Market T rends
6.2.2 Market Forecast
6.3 Others
6.3.1 Mark et T rends
6.3.2 Mark et Forecast
7 Market Breakup by Route of Administration

10. Table of
Contents
7.1 Intramuscular Vaccination
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Intradermal Vaccination
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 Subcutaneous Vaccination
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Mark et Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Clinics
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Others
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Mark et Forecast
9.1.1.2 Mark et Trends
9.1.2 Canada
For more information, visit :
https://www.imarcgroup.com/vaccine -delivery-devices-
market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com